Exane Derivatives’s Pennant Park Investment Corp PNNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1
Closed -$6 688
2019
Q2
$6 Hold
1
﹤0.01% 664
2019
Q1
$7 Sell
1
-799
-100% -$5.62K ﹤0.01% 628
2018
Q4
$5.09K Hold
800
﹤0.01% 492
2018
Q3
$5.98K Sell
800
-2,495
-76% -$18.8K ﹤0.01% 459
2018
Q2
$22.9K Buy
3,295
+433
+15% +$3.04K ﹤0.01% 427
2018
Q1
$19.2K Sell
2,862
-1,378
-33% -$9.55K ﹤0.01% 396
2017
Q4
$29.3K Sell
4,240
-2,875
-40% -$21.3K 0.01% 371
2017
Q3
$53.4K Sell
7,115
-989
-12% -$7.43K 0.01% 302
2017
Q2
$59.9K Buy
+8,104
New +$62.5K 0.01% 304

Other funds holding PNNT

Exane Derivatives's PNNT Position: Q3 2019 in Review

Exane Derivatives sold out of Pennant Park Investment Corp (PNNT) in Q3 2019, closing a stake of 1 share — an estimated $6 sold.

Exane Derivatives first reported a position in PNNT in Q2 2017 and held it in 9 quarters. The position peaked at $59.9K in Q2 2017. 110 funds tracked by Wall St. Rank hold PNNT as of Q3 2019.

  • Exane Derivatives reported no remaining Pennant Park Investment Corp position as of Q3 2019 after selling out during the quarter.
  • Exane Derivatives sold 1 Pennant Park Investment Corp share in Q3 2019, an estimated $6.
  • Exane Derivatives first reported a position in Pennant Park Investment Corp in Q2 2017 and held it in 9 quarters.
  • Exane Derivatives's Pennant Park Investment Corp position peaked at $59.9K in Q2 2017.
  • 110 funds tracked by Wall St. Rank held Pennant Park Investment Corp as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.